Found 201 results
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez, Kemper, C. A., and Deresinski, S. C., “Dysfunctional monocytes from a patient with disseminated Mycobacterium kansasii infection are activated in vitro and in vivo by GM-CSF.”, Biotherapy (Dordrecht, Netherlands), vol. 8, no. 2, pp. 135-42, 1994.
L. E. Bermudez and Young, L. S., “Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.”, Antimicrobial agents and chemotherapy, vol. 32, no. 8, pp. 1149-53, 1988.
L. E. Bermudez, Wagner, D., and Sosnowska, D., “Mechanisms of Mycobacterium avium pathogenesis.”, Archivum immunologiae et therapiae experimentalis, vol. 48, no. 6, pp. 521-7, 2000.
L. E. Bermudez, Wu, M., Petrofsky, M., and Young, L. S., “Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages.”, Infection and immunity, vol. 60, no. 10, pp. 4245-52, 1992.
L. E. Bermudez, Petrofsky, M., and Stevens, P., “Treatment with recombinant granulocyte colony-stimulating factor (Filgrastin) stimulates neutrophils and tissue macrophages and induces an effective non-specific response against Mycobacterium avium in mice.”, Immunology, vol. 94, no. 3, pp. 297-303, 1998.
L. E. Bermudez, Inderlied, C., and Young, L. S., “Stimulation with cytokines enhances penetration of azithromycin into human macrophages.”, Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
L. E. Bermudez, Motamedi, N., Chee, C., Baimukanova, G., Kolonoski, P., Inderlied, C., Aralar, P., Wang, G., Phan, L. Tam, and Young, L. S., “EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium.”, Antimicrobial agents and chemotherapy, vol. 51, no. 5, pp. 1666-70, 2007.
L. E. Bermudez and Goodman, J., “Mycobacterium tuberculosis invades and replicates within type II alveolar cells.”, Infection and immunity, vol. 64, no. 4, pp. 1400-6, 1996.
L. E. Bermudez and Young, L. S., “Ethanol and survival of Mycobacterium avium complex within macrophages.”, Progress in clinical and biological research, vol. 325, pp. 383-91, 1990.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S., “Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.”, Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.
L. E. Bermudez, Danelishvili, L., Babrack, L., and Pham, T., “Evidence for genes associated with the ability of Mycobacterium avium subsp. hominissuis to escape apoptotic macrophages.”, Front Cell Infect Microbiol, vol. 5, p. 63, 2015.
L. E. Bermudez, Young, L. S., and Inderlied, C. B., “Rifabutin and sparfloxacin but not azithromycin inhibit binding of Mycobacterium avium complex to HT-29 intestinal mucosal cells.”, Antimicrobial agents and chemotherapy, vol. 38, no. 5, pp. 1200-2, 1994.
L. E. Bermudez, “Production of transforming growth factor-beta by Mycobacterium avium-infected human macrophages is associated with unresponsiveness to IFN-gamma.”, Journal of immunology (Baltimore, Md. : 1950), vol. 150, no. 5, pp. 1838-45, 1993.
L. E. Bermudez and Young, L. S., “Phagocytosis and intracellular killing of Mycobacterium avium complex by human and murine macrophages.”, Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 20, no. 2, pp. 191-201, 1987.
L. E. Bermudez and Petrofsky, M., “Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells.”, Infection and immunity, vol. 67, no. 6, pp. 3108-11, 1999.
L. E. Bermudez, Wu, M., Martinelli, J., and Young, L. S., “Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages.”, Lymphokine and cytokine research, vol. 10, no. 5, pp. 413-9, 1991.
L. E. Bermudez and Petrofsky, M., “Regulation of the expression of Mycobacterium avium complex proteins differs according to the environment within host cells.”, Immunology and cell biology, vol. 75, no. 1, pp. 35-40, 1997.
L. E. Bermudez, Yau-Young, A. O., Lin, J. P., Cogger, J., and Young, L. S., “Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides.”, The Journal of infectious diseases, vol. 161, no. 6, pp. 1262-8, 1990.
L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S., “Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”, The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
L. E. Bermudez, Shelton, K., and Young, L. S., “Comparison of the ability of Mycobacterium avium, M. smegmatis and M. tuberculosis to invade and replicate within HEp-2 epithelial cells.”, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 76, no. 3, pp. 240-7, 1995.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B., “Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.”, Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
L. E. Bermudez and Young, L. S., “Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex.”, Journal of immunology (Baltimore, Md. : 1950), vol. 140, no. 9, pp. 3006-13, 1988.
L. E. Bermudez and Young, L. S., “Tumor necrosis factor alpha stimulates mycobactericidal/mycobacteriostatic activity in human macrophages by a protein kinase C-independent pathway.”, Cellular immunology, vol. 144, no. 2, pp. 258-68, 1992.
L. E. Bermudez, Panza, M., Velasco, E., and Vidal, E., “[Effect of systemic antibiotic therapy on microbial flora of gastrointestinal tract in the hematological patients].”, Revista paulista de medicina, vol. 102, no. 6, pp. 256-9, 1984.
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., “Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice.”, The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.

Pages